$7.5B in emergency congressional coronavirus prep; Sickle cell biotech sets terms for IPO
→ Multiple outlets, including the Washington Post, are reporting that Congress is preparing to approve a $7.5 billion emergency coronavirus spending package. It’s not clear how much of that will go to drug and vaccine development, although the original — and much smaller — White House funding request included $1 billion for vaccines. The bill is reportedly likely to be introduced today and pass the House later this week, before heading to the Senate.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
